Cancer therapy by gene therapy with angiostatin

Drugs of Today

Volumn 37, Issue 12, 2001, Pages 815-821

  Matsumoto, Goichi ^a   Shindo, Junichi ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; COMPLEMENTARY DNA; PLASMINOGEN; VIRUS VECTOR;

CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER RESEARCH; GENE THERAPY; GENE TRANSFER; HUMAN; IN VITRO STUDY; NONVIRAL GENE DELIVERY SYSTEM; QUANTITATIVE ASSAY; REVIEW;

EID: 0035708196     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2001.37.12.662113     Document Type: Review

References (44)

1. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
2. Tumor angiogenesis
3. Angiostatin induces and sustains dormancy of human primary tumors in mice
4. Tumor angiogenesis
5. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
6. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
7. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo
8. Suppression of tumor growth with recombinant murine angiostatin
9. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
10. Angiogenesis and tumor metastasis
11. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
12. Angiostatin gene therapy inhibits the growth of murine squamous cell carcinoma in vivo
13. Multiple forms of angiostatin induce apoptosis in endothelial cells
14. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites
15. Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice
16. Suppression of choroidal neovascularization by adenoassociated virus vector expressing angiostatin
17. Adenovirus-mediated gene transfer in canine eyes: A preclinical study for gene therapy of human uveal melanoma
18. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
19. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression
20. Human gene marker/therapy clinical protocols
21. AAV as a viral vector for human gene therapy. Generation of recombinant virus
22. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells
23. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
24. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
25. Issues in the development of gene therapy: Preclinical experiments in E1A gene delivery
26. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLAB7
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. The implications of angiogenesis for the biology and therapy of cancer metastasis
29. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
30. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
31. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer
32. Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy
33. Kringle domains of human angiostatin. Characterization of the antiproliferative activity on endothelial cells
34. Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells
35. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
36. Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTV-neu transgenic mice
37. Novel applications of liposomes
38. Angiostatin suppresses malignant glioma growth in vivo
39. Angiostatin inhibits angiogenesis through apoptosis [abstract]
40. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin
41. Piceatannol, a stilbene phytochemical, inhibits mitochondrial F0F1-ATPase activity by targeting the F1 complex
42. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals
43. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
44. Angiostatin effects on endothelial cells mediated by ceramide and RhoA